Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Franchi

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
JACC. Cardiovascular Interventions|June 25, 2025
Platelet Function Profiles in Patients With Ischemia and Nonobstructed Coronary ArteriesRiccardo Rinaldi, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|February 25, 2023
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysisMattia Galli, Renzo Laborante, Luis Ortega-Paz, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.
Expert Review of Clinical Pharmacology|January 6, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapyClaudio Laudani, Luis Ortega-Paz, Francesco Franchi, et al.
Journal of Thrombosis and Thrombolysis|October 9, 2013
Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Clinical and Translational Science|November 24, 2019
Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary InterventionNihal El Rouby, Adel Alrwisan, Taimour Langaee, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled studyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
Journal of the American Heart Association|March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary InterventionJoseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
JACC. Cardiovascular Interventions|June 25, 2025
Platelet Function Profiles in Patients With Ischemia and Nonobstructed Coronary ArteriesRiccardo Rinaldi, Giovanni Occhipinti, Luis Ortega-Paz, et al.
Thrombosis and Haemostasis|February 25, 2023
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysisMattia Galli, Renzo Laborante, Luis Ortega-Paz, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary InterventionDanwei Shao, Jean G Malavé, Joseph S Rossi, et al.
Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.
Expert Review of Clinical Pharmacology|January 6, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapyClaudio Laudani, Luis Ortega-Paz, Francesco Franchi, et al.
Journal of Thrombosis and Thrombolysis|October 9, 2013
Erratum to: Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Pharmacodynamic effects of EV-077 in patients with diabetes mellitus and coronary artery disease on aspirin or clopidogrel monotherapy: results of an in vitro pilot investigationFabiana Rollini, Antonio Tello-Montoliu, Ronakkumar Patel, et al.
Clinical and Translational Science|November 24, 2019
Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary InterventionNihal El Rouby, Adel Alrwisan, Taimour Langaee, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 5, 2023
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled studyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
Journal of the American Heart Association|March 31, 2017
Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Ad Hoc Percutaneous Coronary InterventionJoseph M Sweeny, Dominick J Angiolillo, Francesco Franchi, et al.
Pageof 15